Login to Your Account

UK Consolidation Continues As British Biotech, Vernalis Merging

By Nuala Moran

Wednesday, July 9, 2003
LONDON - UK biotechnology reached the end of an era last week with the announcement that British Biotech plc will take over Vernalis plc in an agreed-to £48 million (US$79.7 million) deal, ditching the British Biotech moniker and closing the company's facility in Oxford. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription